US Broker Ratings

STAAR Surgical Company (STAA)

⚠️ No article content returned.

..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating the Diagnostics Landscape with a 63.79% Potential Upside

Investors focusing on the healthcare sector would do well to keep an eye on Myriad Genetics, Inc. (NASDAQ: MYGN), a key player in the diagnostics and research industry. With a..

Sana Biotechnology (SANA) Investor Outlook: Analyzing the 165% Upside Potential

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering entity in the biotechnology sector, is rapidly capturing investor attention with its promising growth potential. Specializing in the engineering of cells as medicines,..

iRadimed Corporation (IRMD) Stock Analysis: Unpacking a 20% Upside Potential in the Healthcare Sector

iRadimed Corporation (NASDAQ: IRMD) stands out as a compelling opportunity within the medical devices industry, promising significant growth potential for investors. With a current market capitalization of $1.28 billion, the..

PureTech Health plc (PRTC) Stock Analysis: A Biotech Powerhouse with 542.70% Revenue Growth

For investors with a keen eye on the biotechnology sector, PureTech Health plc (PRTC) presents an intriguing opportunity. Based in Boston, Massachusetts, PureTech operates within the healthcare sector, focusing on..

MBX Biosciences, Inc. (MBX) Stock Analysis: Unveiling a 115% Upside Potential in Biotechnology

In the dynamic and ever-evolving world of biotechnology, MBX Biosciences, Inc. (MBX) emerges as a compelling story for investors seeking substantial growth potential. With a market cap of $1.35 billion,..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Unpacking a 17.65% Potential Upside in the Healthcare Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a noteworthy player in the healthcare sector, specifically within the niche of medical care facilities. Headquartered in Boca Raton, Florida, the company..

Zymeworks Inc. (ZYME) Stock Analysis: A Biotech Powerhouse with 67.72% Potential Upside

Zymeworks Inc. (ZYME), a leading biotechnology company in the healthcare sector, continues to capture investor attention with its impressive growth potential and innovative pipeline. Based in Middletown, Delaware, this biotech..

RxSight, Inc. (RXST) Stock Analysis: Navigating a 49% Potential Upside with Caution

RxSight, Inc. (NASDAQ: RXST) presents a compelling mix of risks and opportunities for investors in the healthcare sector, particularly in the niche field of medical devices. Specializing in innovative solutions..

Verastem, Inc. (VSTM) Stock Analysis: Exploring a Potential 189.95% Upside for Investors

Verastem, Inc. (NASDAQ: VSTM), a development-stage biopharmaceutical company, is drawing significant attention in the biotechnology sector. With a current market capitalization of $511.2 million, Verastem is making strides in the..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Unveiling a 28.65% Upside Potential in the Biotech Sector

Investors with a keen eye on the biotechnology sector should take note of Stoke Therapeutics, Inc. (NASDAQ: STOK), a company that is capturing attention with its innovative approach to treating..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Unpacking the 20.83% Potential Upside for Investors

In the rapidly evolving landscape of biotechnology, Maze Therapeutics, Inc. (NASDAQ: MAZE) emerges as a compelling player with promising prospects for individual investors. With its focus on developing precision medicines..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Assessing a 43% Potential Upside Amidst Challenging Metrics

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a key player in the biotechnology sector, presents a compelling case for investors looking at the healthcare landscape. With a market capitalization of $1.11..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unlocking a 153.81% Potential Upside in Biotechnology

Investors with a keen eye on the biotechnology sector may want to closely examine Tectonic Therapeutic, Inc. (NASDAQ: TECX). With its market capitalization standing at $578.88 million, this Watertown, Massachusetts-based..

Orthofix Medical Inc. (OFIX) Stock Analysis: A Look at Its 47% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector, operates within the medical devices industry and specializes in innovative solutions for global spine and limb reconstruction. With..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 48.35% Potential Upside in the Healthcare SaaS Market

For investors seeking opportunities in the healthcare technology sector, HealthStream, Inc. (NASDAQ: HSTM) offers an intriguing prospect. As a leading provider of Software-as-a-Service (SaaS) applications tailored for healthcare organizations, HealthStream..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Unveiling a 233% Potential Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO), a pioneering entity in the field of regenerative medicine, offers investors a striking opportunity with a potential upside of 233.33%, according to recent analyst ratings...

Personalis, Inc. (PSNL) Stock Analysis: A 58.95% Potential Upside in Cancer Genomic Testing

Investors eyeing opportunities in the healthcare sector might want to take a closer look at Personalis, Inc. (PSNL), a company making significant strides in the diagnostics and research industry. With..

SIGA Technologies Inc. (SIGA) Stock Analysis: Evaluating the Undervalued Potential in Healthcare

SIGA Technologies Inc. (SIGA), a key player in the healthcare sector, specifically within the drug manufacturing industry, has carved a niche in the health security market with its flagship antiviral..

CorMedix Inc. (CRMD) Stock Analysis: A Biotech Bet with a 131% Upside Potential

CorMedix Inc. (NASDAQ: CRMD), a dynamic player in the biotechnology sector, is piquing investor interest with its promising therapeutic solutions and enticing valuation metrics. With a market capitalization of approximately..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds